1-3 of 3
Koji Izutsu
Close
Sort by
Journal Articles

Darinaparsin in patients with relapsed or refractory peripheral T-cell lymphoma: results of an Asian phase 2 study

Clinical Trials & Observations
Won-Seog Kim, Noriko Fukuhara, Dok-Hyun Yoon, Kazuhito Yamamoto, Toshiki Uchida, Eiju Negoro, Koji Izutsu, Yasuhito Terui, Hideaki Nakajima, Kiyoshi Ando, Youko Suehiro, Hye Jin Kang, Po-Shen Ko, Fumiko Nagahama, Yusuke Sonehara, Hirokazu Nagai, Hwei-Fang Tien, Yok-Lam Kwong, Kensei Tobinai
Journal: Blood Advances
Blood Adv (2023) 7 (17): 4903–4912.
https://doi.org/10.1182/bloodadvances.2022008615
Published: 2023
Journal Articles

Health-related quality of life with lisocabtagene maraleucel vs standard of care in relapsed or refractory LBCL

Clinical Trials & Observations
Jeremy S. Abramson, Patrick B. Johnston, Manali Kamdar, Sami Ibrahimi, Koji Izutsu, Jon Arnason, Bertram Glass, Pim Mutsaers, Matthew Lunning, Julia Braverman, Fei Fei Liu, Alessandro Crotta, Sandrine Montheard, Alessandro Previtali, Shien Guo, Ling Shi, Scott R. Solomon
Journal: Blood Advances
Blood Adv (2022) 6 (23): 5969–5979.
https://doi.org/10.1182/bloodadvances.2022008106
Published: 2022
Includes: Supplemental data
Journal Articles

Primary human herpesvirus 8–negative effusion-based lymphoma: a large B-cell lymphoma with favorable prognosis

Daisuke Kaji, Yasunori Ota, Yasuharu Sato, Koji Nagafuji, Yasunori Ueda, Masataka Okamoto, Yasushi Terasaki, Naoko Tsuyama, Kosei Matsue, Tomohiro Kinoshita, Go Yamamoto, Shuichi Taniguchi, Shigeru Chiba, Koichi Ohshima, Koji Izutsu
Journal: Blood Advances
Blood Adv (2020) 4 (18): 4442–4450.
https://doi.org/10.1182/bloodadvances.2020002293
Published: 2020
Includes: Supplemental data